|
1
|
Yadav AK, Singh P and Khunger N:
Clinicopathologic analysis of stable and unstable vitiligo: A study
of 66 cases. Am J Dermatopathol. 38:608–613. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shi H, Lin B, Huang Y, Wu J, Zhang H, Lin
C, Wang Z, Zhu J, Zhao Y, Fu X, et al: Basic fibroblast growth
factor promotes melanocyte migration via activating
PI3K/Akt-Rac1-FAK-JNK and ERK signaling pathways. IUBMB Life.
68:735–747. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Wang X, Du J, Wang T, Zhou C, Shen Y, Ding
X, Tian S, Liu Y, Peng G, Xue S, et al: Prevalence and clinical
profile of vitiligo in China: A community-based study in six
cities. Acta Derm Venereol. 93:62–65. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Grimes PE and Miller MM: Vitiligo: Patient
stories, self-esteem, and the psychological burden of disease. Int
J Womens Dermatol. 4:32–37. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hadi A, Wang JF, Uppal P, Penn LA and
Elbuluk N: Comorbid diseases of vitiligo: A 10-year cross-sectional
retrospective study of an urban US population. J Am Acad Dermatol.
82:628–633. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yuan X, Meng D, Cao P, Sun L, Pang Y, Li
Y, Wang X, Luo Z, Zhang L and Liu G: Identification of pathogenic
genes and transcription factors in vitiligo. Dermatol Ther
(Heidelb). 32(e13025)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Galeone M, Colucci R, Dragoni F and
Moretti S: Can environmental factors contribute in triggering
vitiligo and associated autoimmune thyroid diseases? Clinical
series possibly related to the Chernobyl nuclear accident. G Ital
Dermatol Venereol. 153:729–730. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Laddha NC, Dwivedi M, Gani AR, Mansuri MS
and Begum R: Tumor necrosis factor B (TNFB) genetic variants and
its increased expression are associated with vitiligo
susceptibility. PLoS One. 8(e81736)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Al-Harthi F, Zouman A, Arfin M, Tariq M
and Al-Asmari A: Tumor necrosis factor-α and -β genetic
polymorphisms as a risk factor in Saudi patients with vitiligo.
Genet Mol Res. 12:2196–2204. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Veiga-Castelli L, Oliveira ML, Pereira A,
Debortoli G, Marcorin L, Fracasso N, Silva G, Souza A, Massaro J,
Simões AL, et al: HLA-G polymorphisms are associated with
non-segmental vitiligo among Brazilians. Biomolecules.
9(9)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yi X, Cui T, Li S, Yang Y, Chen J, Guo S,
Jian Z, Li C, Gao T, Liu L, et al: Identification of the risk HLA-A
alleles and autoantigen in Han Chinese vitiligo patients and the
association of CD8+T cell reactivity with disease characteristics.
Med Sci Monit. 24:6489–6497. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li J, Yan M, Zhang Y, Feng C, Wang H, Wang
C and Sun L: Meta-analysis of the association between NLRP1
polymorphisms and the susceptibility to vitiligo and associated
autoimmune diseases. Oncotarget. 8:88179–88188. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sun Y, Zuo X, Zheng X, Zhou F, Liang B,
Liu H, Chang R, Gao J, Sheng Y, Cui H, et al: A comprehensive
association analysis confirms ZMIZ1 to be a susceptibility gene for
vitiligo in Chinese population. J Med Genet. 51:345–353.
2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang SK, Hong M, Choi H, Zhao W, Jung Y,
Haritunians T, Ye BD, Kim KJ, Park SH, Lee I, et al: Immunochip
analysis identification of 6 additional susceptibility loci for
Crohn's disease in Koreans. Inflamm Bowel Dis. 21:1–7.
2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rakowski LA, Garagiola DD, Li CM, Decker
M, Caruso S, Jones M, Kuick R, Cierpicki T, Maillard I and Chiang
MY: Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute
T lymphoblastic leukemias. Cancer Res. 73:930–941. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Peng Y, Lee J, Zhu C and Sun Z: A novel
role for protein inhibitor of activated STAT (PIAS) proteins in
modulating the activity of Zimp7, a novel PIAS-like protein, in
androgen receptor-mediated transcription. J Biol Chem.
285:11465–11475. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Xu L, Zhang Z, Xie T, Zhang X and Dai T:
Inhibition of BDNF-AS Provides Neuroprotection for Retinal Ganglion
Cells against Ischemic Injury. PLoS One.
11(e0164941)2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Schnoor M: Endothelial actin-binding
proteins and actin dynamics in leukocyte transendothelial
migration. J Immunol. 194:3535–3541. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang DG, Xu XH, Ma HJ, Li CR, Yue XZ, Gao
J and Zhu WY: Stem cell factor combined with matrix proteins
regulates the attachment and migration of melanocyte precursors of
human hair follicles in vitro. Biol Pharm Bull. 36:1317–1325.
2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Thingnes J, Lavelle TJ, Gjuvsland AB,
Omholt SW and Hovig E: Towards a quantitative understanding of the
MITF-PIAS3-STAT3 connection. BMC Syst Biol. 6(11)2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim HJ, Choi CP, Uhm YK, Kim YI, Lee JW,
Yoon SH, Chung JH and Lee MH: The association between endothelin-1
gene polymorphisms and susceptibility to vitiligo in a Korean
population. Exp Dermatol. 16:561–566. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jeong KH, Shin MK, Uhm YK, Kim HJ, Chung
JH and Lee MH: Association of TXNDC5 gene polymorphisms and
susceptibility to nonsegmental vitiligo in the Korean population.
Br J Dermatol. 162:759–764. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ben Ahmed M, Zaraa I, Rekik R,
Elbeldi-Ferchiou A, Kourda N, Belhadj Hmida N, Abdeladhim M, Karoui
O, Ben Osman A, Mokni M, et al: Functional defects of peripheral
regulatory T lymphocytes in patients with progressive vitiligo.
Pigment Cell Melanoma Res. 25:99–109. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Lan CC, Wu CS, Chiou MH, Chiang TY and Yu
HS: Low-energy helium-neon laser induces melanocyte proliferation
via interaction with type IV collagen: Visible light as a
therapeutic option for vitiligo. Br J Dermatol. 161:273–280.
2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Goldstein NB, Koster MI, Hoaglin LG,
Spoelstra NS, Kechris KJ, Robinson SE, Robinson WA, Roop DR, Norris
DA and Birlea SA: Narrow band ultraviolet B treatment for human
vitiligo is associated with proliferation, migration, and
differentiation of melanocyte precursors. J Invest Dermatol.
135:2068–2076. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Song Y, Zhong M and Cai FC: Oxcarbazepine
causes neurocyte apoptosis and developing brain damage by
triggering Bax/Bcl-2 signaling pathway mediated caspase 3
activation in neonatal rats. Eur Rev Med Pharmacol Sci. 22:250–261.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu PF, Chen WP, Bao JP and Wu LD:
Paeoniflorin inhibits IL-1β -induced chondrocyte apoptosis by
regulating the Bax/Bcl-2/caspase-3 signaling pathway. Mol Med Rep.
17:6194–6200. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Keswell D, Davids LM and Kidson SH:
Migration of human melanocytes into keratinocyte monolayers in
vitro. J Dermatol Sci. 66:160–163. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
AlGhamdi KM, Kumar A, Ashour AE and
AlGhamdi AA: A comparative study of the effects of different
low-level lasers on the proliferation, viability, and migration of
human melanocytes in vitro. Lasers Med Sci. 30:1541–1551.
2015.PubMed/NCBI View Article : Google Scholar
|
